{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:10:20Z","timestamp":1770041420864,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ad.2023.01.010","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T10:39:45Z","timestamp":1681555185000},"page":"T402-T412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["[Translated article] Modern Concepts in Melanocytic Tumors"],"prefix":"10.1016","volume":"114","author":[{"given":"A.","family":"Fernandez-Flores","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.01.010_bib0390","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000372-200310000-00001","article-title":"BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin","volume":"25","author":"Uribe","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0395","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.0022-202X.2004.22225.x","article-title":"BRAF mutations are common somatic events in melanocytic nevi","volume":"122","author":"Kumar","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2023.01.010_bib0400","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2133.1994.tb08460.x","article-title":"Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi","volume":"131","author":"Carr","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2023.01.010_bib0405","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.jid.5700490","article-title":"Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations","volume":"127","author":"Bauer","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2023.01.010_bib0410","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archderm.1996.03890360063011","article-title":"Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors","volume":"132","author":"Luther","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2023.01.010_bib0415","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0733-8635(18)30065-2","article-title":"The epidemiology of acquired melanocytic nevi. A brief review","volume":"13","author":"Gallagher","year":"1995","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ad.2023.01.010_bib0420","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1751-1097.2005.tb00196.x","article-title":"Molecular responses to stress induced in normal human caucasian melanocytes in culture by exposure to simulated solar UV","volume":"81","author":"Marrot","year":"2005","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.ad.2023.01.010_bib0425","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/em.22370","article-title":"Solar ultraviolet-induced DNA damage response: melanocytes story in transformation to environmental melanomagenesis","volume":"61","author":"Sarkar","year":"2020","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.ad.2023.01.010_bib0430","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1158\/0008-5472.CAN-19-0839","article-title":"Deciphering mechanisms of UVR-induced tumoral immune checkpoint regulation against melanoma","volume":"79","author":"Sahu","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.ad.2023.01.010_bib0435","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/978-0-387-77574-6_13","article-title":"UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer","volume":"624","author":"Rass","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ad.2023.01.010_bib0440","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ijc.21196","article-title":"Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma","volume":"117","author":"Purdue","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ad.2023.01.010_bib0445","first-page":"d1024","article-title":"UV damage DNA repair and skin carcinogenesis","volume":"7","author":"Cleaver","year":"2002","journal-title":"Front Biosci"},{"key":"10.1016\/j.ad.2023.01.010_bib0450","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2023.01.010_bib0455","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1365-4632.2008.03818.x","article-title":"Lack of oncogenic mutations in the c-Met catalytic tyrosine kinase domain in acral lentiginous melanoma","volume":"47","author":"Seidl","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2023.01.010_bib0460","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/pcmr.12279","article-title":"The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis","volume":"27","author":"Furney","year":"2014","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.ad.2023.01.010_bib0465","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/BF00440604","article-title":"The carcinogenic risks of modern tanning equipment: is UV-A safer than UV-B?","volume":"280","author":"Van Weelden","year":"1988","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ad.2023.01.010_bib0470","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.142.12.4213","article-title":"Rapid recovery of Langerhans cell alloreactivity, without induction of autoreactivity, after in vivo ultraviolet A, but not ultraviolet B exposure of human skin","volume":"142","author":"Baadsgaard","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.ad.2023.01.010_bib0475","doi-asserted-by":"crossref","first-page":"9985","DOI":"10.3390\/ijms23179985","article-title":"NAD\/NAMPT and mTOR pathways in melanoma: drivers of drug resistance and prospective therapeutic targets","volume":"23","author":"Indini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ad.2023.01.010_bib0480","doi-asserted-by":"crossref","first-page":"129722","DOI":"10.1016\/j.bbagen.2020.129722","article-title":"The effects of p53 gene inactivation on mutant proteome expression in a human melanoma cell model","volume":"1864","author":"Faktor","year":"2020","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.ad.2023.01.010_bib0485","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bbagen.2018.01.018","article-title":"Melanoma metabolism contributes to the cellular responses to MAPK\/ERK pathway inhibitors","volume":"1862","author":"Marchetti","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.ad.2023.01.010_bib0490","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.2147\/IJGM.S309616","article-title":"Nomogram incorporating the WNT\/\u03b2-catenin signaling pathway for predicting the survival of cutaneous melanoma","volume":"14","author":"Zhou","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.ad.2023.01.010_bib0495","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.18632\/oncotarget.1892","article-title":"Pathways and therapeutic targets in melanoma","volume":"5","author":"Shtivelman","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ad.2023.01.010_bib0500","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.bbamcr.2016.01.025","article-title":"Roads to melanoma: key pathways and emerging players in melanoma progression and oncogenic signaling","volume":"1863","author":"Paluncic","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ad.2023.01.010_bib0505","first-page":"839","article-title":"Regulation of ERK3\/MAPK6 expression by BRAF","volume":"29","author":"Hoeflich","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ad.2023.01.010_bib0510","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/0008-5472.CAN-08-3934","article-title":"Mitogen-activated protein kinase inhibition induces translocation of Bmf to promote apoptosis in melanoma","volume":"69","author":"VanBrocklin","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ad.2023.01.010_bib0515","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/CCO.0000000000000271","article-title":"The role of mitogen-activated protein targeting in melanoma beyond BRAFV600","volume":"28","author":"Sullivan","year":"2016","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ad.2023.01.010_bib0520","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2559.2009.03452.x","article-title":"Molecular cytogenetics of cutaneous melanocytic lesions \u2013 diagnostic, prognostic and therapeutic aspects","volume":"56","author":"Blokx","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.ad.2023.01.010_bib0525","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41417-021-00424-3","article-title":"Protooncogene MYC drives human melanocyte melanogenesis and senescence","volume":"29","author":"San Juan","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.ad.2023.01.010_bib0530","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-4939-6670-7_17","article-title":"Senescence-like phenotypes in human nevi","volume":"1534","author":"Joselow","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ad.2023.01.010_bib0535","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1038\/onc.2017.292","article-title":"Pathways from senescence to melanoma: focus on MITF sumoylation","volume":"36","author":"Leclerc","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ad.2023.01.010_bib0540","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sder.2010.10.004","article-title":"Pathways to melanoma","volume":"29","author":"Ko","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.ad.2023.01.010_bib0545","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/jid.2012.75","article-title":"Melanoma genetics: recent findings take us beyond well-traveled pathways","volume":"132","author":"Law","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2023.01.010_bib0550","series-title":"WHO classification of skin tumours","first-page":"66","article-title":"Melanocytic tumour classification and the pathway concept of melanoma pathogenesis","author":"Elder","year":"2018"},{"key":"10.1016\/j.ad.2023.01.010_bib0555","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/jdv.18453","article-title":"A review of nevus-associated melanoma: what is the evidence?","volume":"36","author":"Dessinioti","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2023.01.010_bib0560","first-page":"e2022094","article-title":"Prevalence and clinical\u2013pathological features of nevus-associated versus de novo melanoma: a retrospective cross-sectional study of 2806 cases","volume":"12","author":"Lai","year":"2022","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.ad.2023.01.010_bib0565","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1053\/j.semdp.2022.02.001","article-title":"Update on classification of melanocytic tumors and the role of immunohistochemistry and molecular techniques","volume":"39","author":"Yeh","year":"2022","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0570","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pathol.2015.12.007","article-title":"Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy","volume":"48","author":"Wiesner","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.ad.2023.01.010_bib0575","doi-asserted-by":"crossref","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","article-title":"The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway","volume":"144","author":"Elder","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ad.2023.01.010_bib0580","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03401664","article-title":"The CDKN2A (p16) gene and human cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Mol Med"},{"key":"10.1016\/j.ad.2023.01.010_bib0585","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular senescence and tumor suppressor gene p16","volume":"130","author":"Rayess","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ad.2023.01.010_bib0590","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jnci\/94.6.446","article-title":"p16(Ink4a) in melanocyte senescence and differentiation","volume":"94","author":"Sviderskaya","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ad.2023.01.010_bib0595","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjc.6603283","article-title":"Cellular senescence in naevi and immortalisation in melanoma: a role for p16?","volume":"95","author":"Gray-Schopfer","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ad.2023.01.010_bib0600","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/onc.2010.419","article-title":"The p16(INK4A) tumor suppressor regulates cellular oxidative stress","volume":"30","author":"Jenkins","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ad.2023.01.010_bib0605","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/his.14583","article-title":"Spitz melanocytic tumours \u2013 a review","volume":"80","author":"Yeh","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.ad.2023.01.010_bib0610","doi-asserted-by":"crossref","first-page":"889223","DOI":"10.3389\/fonc.2022.889223","article-title":"The spectrum of spitz melanocytic lesions: from morphologic diagnosis to molecular classification","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ad.2023.01.010_bib0615","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5644\/ama2006-124.333","article-title":"An update on molecular genetic aberrations in spitz melanocytic proliferations: correlation with morphological features and biological behavior","volume":"50","author":"\u0160ekoranja","year":"2021","journal-title":"Acta Med Acad"},{"key":"10.1016\/j.ad.2023.01.010_bib0620","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.humpath.2016.07.029","article-title":"Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions","volume":"58","author":"Harms","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0625","doi-asserted-by":"crossref","first-page":"5356737","DOI":"10.1155\/2017\/5356737","article-title":"The prognostic value of HRAS mRNA expression in cutaneous melanoma","volume":"2017","author":"Wan","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ad.2023.01.010_bib0630","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41379-019-0445-z","article-title":"Spitz melanoma is a distinct subset of spitzoid melanoma","volume":"33","author":"Raghavan","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0635","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.3390\/ijms23084211","article-title":"The morpho-molecular landscape of spitz neoplasms","volume":"23","author":"Dal Pozzo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.ad.2023.01.010_bib0640","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41379-019-0390-x","article-title":"New and evolving concepts of melanocytic nevi and melanocytomas","volume":"33","author":"Yeh","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0645","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1111\/ajd.13408","article-title":"BAP1-inactivated melanocytic tumour with borderline histopathological features (BAP1-inactivated melanocytoma): a case report and a reappraisal","volume":"62","author":"Ferrara","year":"2021","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.ad.2023.01.010_bib0650","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.humpath.2014.10.015","article-title":"BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations","volume":"46","author":"Piris","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0655","series-title":"GeneReviews(\u00ae)","article-title":"BAP1 tumor predisposition syndrome","author":"Pilarski","year":"1993"},{"key":"10.1016\/j.ad.2023.01.010_bib0660","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.3390\/cancers14174105","article-title":"Correlation between BAP1 localization driver mutations, and patient survival in uveal melanoma","volume":"14","author":"Cole","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ad.2023.01.010_bib0665","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/DAD.0000000000001551","article-title":"BAP-1 expression status by immunohistochemistry in cellular blue nevus and blue nevus-like melanoma","volume":"42","author":"Chen","year":"2020","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0670","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41379-022-01026-6","article-title":"Towards diagnostic criteria for malignant deep penetrating melanocytic tumors using single nucleotide polymorphism array and next-generation sequencing","volume":"35","author":"Ebbelaar","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0675","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.5858\/arpa.2021-0301-LE","article-title":"\u03b2-Catenin and periodic acid-schiff distinguish granular cell nevus from deep penetrating nevus","volume":"145","author":"Eiger-Moscovich","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ad.2023.01.010_bib0680","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/PAS.0000000000001513","article-title":"Diagnostic utility of LEF1 immunohistochemistry in differentiating deep penetrating nevi from histologic mimics","volume":"44","author":"Raghavan","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0685","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/cup.13106","article-title":"Histological features and outcome of inverted type-A melanocytic nevi","volume":"45","author":"Dadras","year":"2018","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0690","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/PAS.0000000000001888","article-title":"Attempting to solve the pigmented epithelioid melanocytoma (PEM) conundrum: PRKAR1A inactivation can occur in different genetic backgrounds (common blue, and spitz subgroups) with variation in their clinicopathologic characteristics","volume":"46","author":"De la Fouchardiere","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0695","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/PAS.0000000000000902","article-title":"Genomic analysis of pigmented epithelioid melanocytomas reveals recurrent alterations in PRKAR1A, and PRKCA genes","volume":"41","author":"Cohen","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0700","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/ijms18081769","article-title":"Pigmented epithelioid melanocytoma (PEM)\/animal type melanoma (ATM): quest for an origin. Report of one unusual case indicating follicular origin and another arising in an intradermal nevus","volume":"18","author":"Tarasen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ad.2023.01.010_bib0705","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/cup.14091","article-title":"Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi","volume":"48","author":"Gill","year":"2021","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0710","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0000000000000351","article-title":"A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children","volume":"39","author":"Y\u00e9lamos","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0715","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cll.2017.05.001","article-title":"Blue nevi and related tumors","volume":"37","author":"Zembowicz","year":"2017","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.ad.2023.01.010_bib0720","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41379-021-00976-7","article-title":"Novel insights into the BAP1-inactivated melanocytic tumor","volume":"35","author":"Donati","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0725","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/DAD.0000000000000568","article-title":"Melanocytic nevi of special sites","volume":"38","author":"Ahn","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0730","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1590\/S1807-59322011000300023","article-title":"Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma \u2013 review article","volume":"66","author":"Silva","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ad.2023.01.010_bib0735","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/DAD.0000000000000380","article-title":"Fluorescence in situ hybridization for melanoma diagnosis: a review and a reappraisal","volume":"38","author":"Ferrara","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0740","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13000-020-00937-9","article-title":"Four-color fluorescence in-situ hybridization is useful to assist to distinguish early stage acral and cutaneous melanomas from dysplastic junctional or compound nevus","volume":"15","author":"Lai","year":"2020","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0745","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00238-009-0369-9","article-title":"Comparative genomic hybridization for the diagnosis of melanoma","volume":"33","author":"Vanison","year":"2010","journal-title":"Eur J Plast Surg"},{"key":"10.1016\/j.ad.2023.01.010_bib0750","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cncr.21372","article-title":"Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction","volume":"104","author":"Lewis","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ad.2023.01.010_bib0755","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/his.14814","article-title":"PRAME is a useful marker for the differential diagnosis of melanocytic tumours and histological mimics","volume":"82","author":"Chen","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.ad.2023.01.010_bib0760","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/diagnostics12092197","article-title":"PRAME immunoexpression in 275 cutaneous melanocytic lesions: a double institutional experience","volume":"12","author":"Cazzato","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ad.2023.01.010_bib0765","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cup.14342","article-title":"Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: superiority to PRAME and correlation with FISH","volume":"50","author":"McAfee","year":"2023","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2023.01.010_bib0770","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11912-021-01104-z","article-title":"Next-generation immunotherapy approaches in melanoma","volume":"23","author":"Buchanan","year":"2021","journal-title":"Curr Oncol Rep"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023002910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023002910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:15:23Z","timestamp":1757553323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731023002910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0001731023002910"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.01.010","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Modern Concepts in Melanocytic Tumors","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.01.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}